BioSpace News Archive

Most of the interview process is out of your hands, for better or for worse. But what you can control are your actions.

Under the terms of the deal, Roche will pay Dicerna $200 million upfront and up to another $1.47 billion for various development, regulatory and commercial milestones.

Researchers with Temple University Health System have found that the Zika virus responds to an HIV drug called rilpivirine, which is marketed by Janssen, a Johnson & Johnson company, as Edurant.

Luminostics, Inc., to receive $10,000 cash prize and recognition from the rapid point-of-care diagnostics industry

ObsEva SA announced that the U.S. Food and Drug Administration has allowed the Company to begin enrolling patients in IMPLANT 3, the U.S pivotal Phase 3 clinical trial of nolasiban in women undergoing embryo transfer following in-vitro fertilization.

GAAP earnings per share (EPS) from continuing operations was a loss of $(0.69) for the third quarter and operating EPS1 was a loss of $(0.39) – both improved compared to prior year.

Reston Hospital Center has recently renewed accreditation as a Center of Excellence in Minimally Invasive Gynecology by Surgical Review Corporation This accreditation distinguishes Reston Hospital Center from many other surgical facilities by providing the highest quality of care to patients as determined by an independent, external process of evaluation.

Martinsried/ Munich Medigene AG announces its participation at the following upcoming scientific and investor conferences.

Visit booth 4631 to see disposable and sterile needles for the delivery of anesthetic

This Halloween, BioSpace has collected six tales of thrills and chills from the pharma and biotech industries that will surely have you covering your eyes in terror.